Antibiotic Biogram of Bacterial Isolates among Patients Suspected of Urinary Tract Infection
Abstract
Resistant bacteria are emerging worldwide as a threat to favourable outcomes of treatment of common infections in community and hospital settings. Urinary tract, gastrointestinal and pyogenic infections are commonly caused by members of Enterobacteriaceae. A total of three hundred and seventy (370) urine samples from patients suspected of Urinary Tract Infections (UTIs) at Rasheed Shekoni Specialist Hospital, Dutse, Nigeria, were collected and microbiologically analyzed. The prevalence of bacterial UTIs in the study population was determined (24.9%). The most prevalent isolates were Escherichia coli 39(42.2%) and Staphylococcus saprophyticus 26(28.3%) followed by K. pneumoniae 9(9.8%), P. vulgaris 9(9.8%), P. mirabilis 7(7.5%) and P. aeruginosa (2.2%) Statistical analysis using chi-square test had shown that there is no significant difference (p>0.05). In-vitro antibiotic susceptibility test have revealed that, almost all the isolates have relatively shown resistance to the tested antibiotics. Resistance to amoxicillin (AM), Augmentin (AU), Pefloxacin (PEF), and Sparfloxacin (SP) are the most common. It was concluded with the fact that E. coli and S. saprophyticus were the most prevalent pathogens of bacterial UTIs in the population; and Streptomycin (S), Gentimicin (CN), Ciproplaxacin (CPX), Rifampicin (RD), Levofloxacin (LEV), Norfloxacin (NB) and Erythromycin (E) are the most promising due to relatively low resistance pattern of the tested isolates to these antibiotics.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.